Trends in M&A and Business Succession in the Long

News Highlights

Japan M&A Center announced trends in M&A and business succession for the long-term care and welfare industry in 2025. For medical institutions, unique schemes such as the transfer of equity interests, changes in members, and refund of funds are becoming options. In business valuation, comprehensive evaluation of fixed assets, licenses, staff, and patient base, in addition to medical profits, is emphasized. Support for stable post-succession operations is also pointed out as essential.

M&A Medical Editorial Department’s Perspective

Although reported as a trend in the long-term care and welfare industry, this matter holds significant implications, particularly for the business succession of clinics and small hospitals. The “transfer of equity interests, changes in members, and refund of funds” cited by Japan M&A Center are precisely the issues that M&A Medical faces daily. In medical institutions, which tend to rely on the individual skills and networks of physicians, the continuity of licenses, staff, and the “patient base,” not just asset valuation, determines business value. As a trend for the near future in 2025, quantifying and evaluating these assessment items specifically will be the key to successful M&A. It is an era where not only simple sales opportunities but also the construction of schemes that look ahead to stable post-succession operations are increasingly required.

Points Highlighted by This News

• The fact that unique schemes for medical corporations (transfer of equity interests, changes in members, refund of funds) are specifically presented as options for business succession.
• The fact that multifaceted evaluations, including fixed assets, licenses, staff, and patient base, in addition to medical profits, are important items for business valuation.
• The necessity of a post-M&A follow-up system is suggested by the trends in the long-term care and welfare industry.
• The fact that these points are already evident as trends for the near future in 2025.

Practical Questions Arising from This News

• How will my clinic’s medical profits and patient base be specifically evaluated in M&A business valuation?
• What are the specific procedures and approximate timelines for executing schemes such as changes in members or refund of funds?
• What kind of support can be received in post-succession follow-up?

If You Feel “Should I Consult Too?”

If you have vague concerns about your clinic’s business succession or have begun to explore concrete options, this news serves as a good opportunity to consider consultation. Especially if you are interested in unique schemes for medical corporations such as the transfer of equity interests or changes in members, or if you are seeking specific information on appropriate business valuation or post-succession support, consulting with an M&A intermediary company with specialized knowledge would be effective. Early consultation increases the possibility of securing more options and favorable terms.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as a Small and Medium Enterprise Agency-certified M&A support institution. Consultations are accepted with strict confidentiality. Free consultation here